Inhibition of Aggregation of Amyloid β42 by Arginine-Containing Small Compounds

Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center

(2011) Deborah D. Soto-Ortega et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Identification of Novel Short Peptide Inhibitors of Soluble 37/48 kDa Oligomers of Amyloid β42

(2011) Takayasu KAWASAKI et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Soluble amyloid  -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

(2011) M. Jin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers

(2010) Anna Nogalska et al.   ACTA NEUROPATHOLOGICA

Selection of Peptide Inhibitors of Soluble Aβ1-42Oligomer Formation by Phage Display

(2010) Takayasu KAWASAKI et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Amyloid oligomers: formation and toxicity of Aβ oligomers

(2010) Masafumi Sakono et al.   FEBS Journal

Polymorphic C-terminal β-Sheet Interactions Determine the Formation of Fibril or Amyloid β-derived Diffusible Ligand-like Globulomer for the Alzheimer Aβ42 Dodecamer

(2010) Buyong Ma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Generation and Therapeutic Efficacy of Highly Oligomer-Specific  -Amyloid Antibodies

(2010) H. Hillen et al.   JOURNAL OF NEUROSCIENCE

Structural Characterization of a Soluble Amyloid β-Peptide Oligomer

(2009) Liping Yu et al.   BIOCHEMISTRY

Computational selection of inhibitors of Aβ aggregation and neuronal toxicity

(2009) Deliang Chen et al.   BIOORGANIC & MEDICINAL CHEMISTRY

The chemistry of Alzheimer’s disease

(2009) Arvi Rauk   CHEMICAL SOCIETY REVIEWS

Aβ-globulomers are formed independently of the fibril pathway

(2008) Gerald P. Gellermann et al.   NEUROBIOLOGY OF DISEASE